Picture Berlin Partner Join Cluster HealthCapital Berlin Brandenburg 650x100px

News > All

Please find below news from the Benelux countries (Belgium, Luxembourg and The Netherlands) as well as about organisations from these countries.

Total search results: 1747 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
TME Pharma N.V.. (1/23/23). "Press Release: TME Pharma Provides Clinical Update on the GLORIA Expansion Arm Testing NOX-A12 in Combination with Radiotherapy and Bevacizumab in Patients with Glioblastoma". Berlin. 2023-01-23
DeuterOncology N.V.. (1/19/23). "Press Release: DeuterOncology closes €5.65M Series A financing round". Liège. 2023-01-19
Qiagen N.V.. (1/17/23). "Press Release: Qiagen Launches EZ2 Connect MDx Platform for Automated Sample Processing in". Venlo. 2023-01-17
BioGeneration Ventures B.V.. (1/17/23). "Press Release: BGV Appoints Jaap de Bruin as FIRST Fund Investment Manager and Promotes Rianne Ellenbroek to Principal". Amsterdam. 2023-01-17
AstraZeneca plc. (1/16/23). "Press Release: Acquisition of Neogene Therapeutics Completed". 2023-01-16
CureVac N.V.. (1/10/23). "Press Release: CureVac Appoints Alexander Zehnder as CEO from April 1, 2023". Mainz & London. 2023-01-10
Qiagen N.V.. (1/9/23). "Press Release: Qiagen Completes Acquisition of Verogen, Strengthening Leadership in Human ID / Forensics with NGS Technologies". Venlo & San Diego, CA. 2023-01-09
European Invesmtent Bank (EIB). (1/9/23). "Press Release: Belgium – ExeVir Lands European Venture Debt Financing to Develop Novel Nanobody COVID-19 Therapy". 2023-01-09
CureVac N.V.. (1/6/23). "Press Release: CureVac Announces Positive Data on Joint COVID-19 and Flu mRNA Vaccine Development Programs". Tübingen & Boston, MA. 2023-01-06
Volta Medical. (1/5/23). "Press Release: Volta Medical Secures €36M in Series B Funding to Support Adoption of its AI Software for Cardiac Ablation, New CFO Introduced". Marseille. 2023-01-05
Synaffix B.V.. (1/4/23). "Press Release: Hummingbird Bioscience and Synaffix Enter License Agreement to Develop a Next Generation Antibody Drug Conjugate (ADC) Program". Amsterdam, San Francisco, CA, et al.. 2023-01-04
European Invesmtent Bank (EIB). (12/23/22). "Press Release: Sweden – EIB Lends €20 Million to Biotech Company for Development of Biopharmaceuticals to Treat Cancer and Inflammatory Diseases". 2022-12-23
Affibody Medical AB. (12/23/22). "Press Release: Affibody Signs €20 Million Loan Agreement with the EIB to Finance the Development of Next Generation’s Biopharmaceuticals against Cancer and Inflammatory Diseases". Solna. 2022-12-23
European Invesmtent Bank (EIB). (12/20/22). "Press Release: Germany – EIB Provides €20 Million in Financing to Innovative Diagnostics Developer Numares". 2022-12-20
Beiersdorf AG. (12/16/22). "Press Release: Beiersdorf Acquires S-Biomedic and Strengthens Expertise in the Field of Acne Treatment". Hamburg. 2022-12-16
MyCellHub N.V.. (12/15/22). "Press Release: MyCellHub Raises EUR 2 Million and Incorporates in US to Help Biotech Manufacturing Become More Intelligent". Hasselt. 2022-12-15
Minervax ApS. (12/15/22). "Press Release: Minervax Announces 72M EUR Financing to Advance Development of Novel Vaccine against Group B Streptococcus". Copenhagen. 2022-12-15
Storm Therapeutics Ltd.. (12/14/22). "Press Release: Storm Therapeutics Announces Closing of USD $30M Series B Financing". Cambridge. 2022-12-14
Corbion N.V.. (12/13/22). "Press Release: Corbion Appoints Jennifer Lindsey as Chief Marketing and Digital Officer". 2022-12-13
Lipotype GmbH. (12/13/22). "Press Release: Lipotype, a Leading Lipidomics Service Provider, Launches US Subsidiary in Cambridge, Massachusetts". Cambridge, MA & Dresden. 2022-12-13
Ion Beam Applications S.A. (IBA). (12/8/22). "Press Release: IBA Wins 10 Proton Therapy System Contract in Spain". Louvain-la-Neuve. 2022-12-08
BioWin. (11/29/22). "Press Release: BioWin Expands Its »Growth & Financing« Member Service by Appointing Two Industry Experts". Gosselies. 2022-11-29
AstraZeneca plc. (11/29/22). "Press Release: AstraZeneca to Acquire Neogene Therapeutics, Accelerating Ambition in Oncology Cell Therapy". 2022-11-29
Full-Life Technologies Ltd.. (11/29/22). "Press Release: Full-Life Technologies to Acquire Focus-X Therapeutics, Bolstering Peptide-focused Radiopharmaceutical Pipeline". Brussels, Watchung, NJ & Shanghai. 2022-11-29
Sotio Biotech a.s.. (11/29/22). "Press Release: Sotio Exercises Option for Novel Antibody-Drug Conjugate Program under Agreement with LegoChem Biosciences". Prague. 2022-11-29
Biomemory S.A.S.. (11/28/22). "Press Release: Biomemory Raises 5 Million Euros Seed Investment to Advance Its Cutting-edge DNA Digital Data Storage Solution". Paris. 2022-11-28
Hemispherian AS. (11/24/22). "Press Release: Hemispherian Raises the First Tranche of a Series A to Fund the Development of Its Novel Cancer Therapeutics". Oslo. 2022-11-24
Catalym GmbH. (11/22/22). "Press Release: Catalym Closes EUR 50 Million Series C Financing to Expand and Accelerate Phase 2 Clinical Development of Visugromab in Patients with Solid Tumors". Oxford. 2022-11-22
Uniqure N.V.. (11/22/22). "Press Release: Uniqure Announces FDA Approval of First Gene Therapy for Adults with Hemophilia B". Research Triangle Park, NC. 2022-11-22
European Invesmtent Bank (EIB). (11/18/22). "Press Release: Marjut Falkstedt Appointed as Chief Executive of the European Investment Fund". 2022-11-18
High-Tech Gründerfonds Management GmbH. (11/17/22). "Press Release: FundaMental Pharma Launches with EUR 10 Million in Seed Financing Led by BGV and Thuja Capital to Advance a First-in-Class Neuroprotectant". Heidelberg. 2022-11-17
Cradle Bio B.V.. (11/17/22). "Press Release: Biotech Startup Cradle Exits Stealth, Raises $5.5M to Design Protein-machines and Cell-factories with AI". 2022-11-17
Azenta, Inc.. (11/8/22). "Press Release: Azenta and the Government of Luxembourg Announce a Memorandum of Understanding to Facilitate Continued Healthcare Technology Development in Luxembourg". Chelmsford, MA. 2022-11-08
BioGeneration Ventures B.V.. (11/8/22). "Press Release: BGV Appoints Elena Ritsou as Venture Partner and Andree Blaukat as Senior Advisor". Amsterdam. 2022-11-08
VectorY B.V.. (11/8/22). "Press Release: VectorY Appoints Sander van Deventer as CEO and Makes Key Appointments to Its Leadership Team". Amsterdam. 2022-11-08
Affimed N.V.. (11/3/22). "Press Release: Affimed and Artiva Biotherapeutics Announce Partnership to Advance Combination Therapy of Innate Cell Engager (ICE) AFM13 and Off-the-Shelf Allogeneic NK Cell Therapy AB-101". Heidelberg & San Diego, CA. 2022-11-03
Novadip Biosciences S.A.. (11/3/22). "Press Release: Novadip Biosciences Raises Additional EUR 40 Million Bringing Total Company Funding to EUR 88 Million". Mont-Saint-Guibert. 2022-11-03
Enzyre B.V.. (11/2/22). "Press Release: Enzyre Closes Series A Financing Round of EUR 12M to Advance Pioneering Diagnostic Technology Platform for Hemophilia Patients". Nijmegen. 2022-11-02
Affimed N.V.. (11/1/22). "Press Release: Affimed to Present at the 2022 Jefferies London Healthcare Conference". Heidelberg. 2022-11-01
Resolve Biosciences GmbH. (10/24/22). "Press Release: Resolve Biosciences Secures $71 Million Series B Financing to Accelerate Commercial Expansion to Meet Global Demand for Molecular Cartography Workflow". Monheim. 2022-10-24
Enhanc3D Genomics Ltd.. (10/20/22). "Press Release: Enhanc3D Genomics Raises £10 Million in Series A Financing to Advance GenLink3D Proprietary Technology Platform". Cambridge. 2022-10-20
Orionis Biosciences. (10/19/22). "Press Release: Orionis Biosciences Secures $55 Million Financing to Support Advancement into Clinic". Boston, MA & Ghent. 2022-10-19
Univercells S.A.. (10/19/22). "Press Release: Univercells Raises € 44 Million in First Close of Its Series D". Brussels. 2022-10-19
Nucleome Therapeutics Ltd.. (10/19/22). "Press Release: Nucleome Therapeutics Raises oversubscribed £37.5 Million Series A Financing to Decode the Dark Matter of the Human Genome and Deliver First-in-Class Precision Medicines". Oxford. 2022-10-19
Andera Partners. (10/10/22). "Press Release: Andera Partners Raises Its Largest Life Sciences Fund at €456M, Demonstrating the Attractiveness of Its Activity and of the Sector". Paris. 2022-10-10
NLC Ventures Netherlands B.V.. (10/5/22). "Press Release: Crainio, an NLC Venture, Sets Out to Revolutionise the Measurement of Intracranial Pressure (ICP) by Developing a Non-invasive Measuring Device". 2022-10-05
Araris Biotech AG. (10/4/22). "Press Release: Araris Biotech Closes $24 Million Financing Round". Zurich. 2022-10-04
Sibylla Biotech S.p.A.. (10/4/22). "Press Release: Sibylla Biotech Raises €23 Million Series A to Advance Protein Degradation by Folding Interference Pipeline and Expand Technology Platform". Verona. 2022-10-04
Azenta, Inc.. (10/3/22). "Press Release: Azenta Announces Completion of B Medical Systems Acquisition". Chelmsford, MA. 2022-10-03
Pheon Therapeutics Ltd.. (9/28/22). "Press Release: Pheon Therapeutics Launches with $68 Million in Financing to Advance Novel Antibody-Drug Conjugates for Treatment of Solid Tumors". London. 2022-09-28
NLC Ventures Netherlands B.V.. (9/27/22). "Press Release: BioDGraft, an NLC Venture, Sets Out to Eliminate the Need for Vein Harvesting in Bypass Surgeries, Proposing a Solution that Lasts for Life". 2022-09-27
Novo Nordisk Foundation. (9/21/22). "Press Release: Major Investment for Developing Denmark’s First Fully Functional Quantum Computer". 2022-09-21
ECBF Management GmbH. (9/20/22). "Press Release: ECBF Leads €10m Series B Investment in Digital Pest Monitoring Provider Trapview to Expand Its Sustainable Agriculture Technology Portfolio". Luxembourg. 2022-09-20
Tridek-One S.A.S.. (9/15/22). "Press Release: Tridek-One Closes a €16 Million Financing Round to Develop First-in-Class Immune Checkpoint Agonists". Paris. 2022-09-15
Kuros Biosciences AG. (9/15/22). "Press Release: Kuros Biosciences Announces Successful CHF 6.0 Million Private Placement (Ad-hoc announcement pursuant to Article 53 of the SIX listing rules)". Schlieren. 2022-09-15
Standing Ovation S.A.S.. (9/14/22). "Press Release: Foodtech Startup Standing Ovation Closes a €12M Series A Financing Round to Accelerate the Development of Its Animal-free Casein and Cheese Substitute Production Process". Paris. 2022-09-14
NLC Ventures Netherlands B.V.. (9/8/22). "Press Release: AIDO, an NLC venture, Has Made It Its Mission to Bring more Control to Physicians Performing Endoscopic Procedures and Lower the Threshold to Expand Complex Interventions". 2022-09-08
Emergence Therapeutics AG. (9/6/22). "Press Release: Emergence Therapeutics Licenses Synaffix ADC Technology Platform in $360M Deal". Amsterdam & Duisburg. 2022-09-06
Pleco Therapeutics B.V.. (9/6/22). "Press Release: Pleco Therapeutics Announces Final Close of Its Series A Financing Raising €17.3m to Progress its Novel Plecoid Product in Acute Myeloid Leukaemia to Regulatory Filing in USA and EU". Nijmegen. 2022-09-06
Affimed N.V.. (9/1/22). "Press Release: Affimed to Present at Upcoming Investor Conferences". Heidelberg. 2022-09-01
The Protein Brewery B.V.. (9/1/22). "Press Release: The Protein Brewery Appoints Sue Garfitt as CEO". Breda. 2022-09-01
AiCuris Anti-infective Cures AG. (9/1/22). "Press Release: AiCuris Appoints Experienced Business Leader Dr. Sabrina Kuttruff-Coqui as Chief Financial Officer". Wuppertal. 2022-09-01
Gilde Healthcare Partners. (8/29/22). "Press Release: Gilde Healthcare Acquires Sanquin Reagents". Utrecht. 2022-08-29
Formycon AG. (8/29/22). "Press Release: European Commission Approves FYB201/Ranivisio (Ranivisio - Ranibizumab), a Biosimilar to Lucentis". Munich, Amsterdam & Zug. 2022-08-29
eTheRNA Immunotherapeutics N.V.. (8/23/22). "Press Release: mRNA Leading Expert Kenneth Chien and Novalis LifeSciences’ Marijn Dekkers Investing EUR 39M Series B2 Financing in mRNA Technology Platform Company eTheRNA". Niel. 2022-08-23
Immatics N.V.. (8/23/22). "Press Release: Immatics Announces First Cancer Patient Treated with Second-generation ACTengine TCR-T Candidate IMA203CD8 Targeting PRAME". Houston, TX & Tübingen. 2022-08-23
Ampersand Capital Partners. (8/22/22). "Press Release: Ampersand Closes Oversubscribed Fund at $1.2 Billion Hard Cap". Wellesley, MA. 2022-08-22
Ryvu Therapeutics S.A.. (8/17/22). "Press Release: EIB to Support Ryvu Therapeutics’ Discovery, Research and Development of New Cancer Treatments with €22 Million". 2022-08-17
Eurobio Scientific S.A.. (8/17/22). "Press Release: Eurobio Scientific Signs an Agreement to Acquire GenDx, International HLA Diagnostics Specialist". Paris. 2022-08-17
Vector BioPharma AG. (8/10/22). "Press Release: Versant Ventures Launches Vector BioPharma AG". Basel. 2022-08-10
Navis Capital Partners. (8/9/22). "Press Release: Navis Capital Partners Announces the Sale of 100% of B Medical Systems to Azenta, Inc". Singapore. 2022-08-09
Immatics N.V.. (8/9/22). "Press Release: Immatics Announces Second Quarter 2022 Financial Results and Business Update". Tübingen & Houston, TX. 2022-08-09
Argenx SE. (8/8/22). "Press Release: Argenx Announces European Commission Approval of Vyvgart (efgartigimod alfa-fcab) for the Treatment of Generalized Myasthenia Gravis". 2022-08-08
Azenta, Inc.. (8/8/22). "Press Release: Azenta Announces Agreement to Acquire B Medical Systems". Chelmsford, MA. 2022-08-08
F2G Ltd.. (8/4/22). "Press Release: F2G Announces $70 Million Financing to Advance Development and Commercialization of New Antifungal Agent Olorofim". Manchester. 2022-08-04
Formycon AG. (8/3/22). "Press Release: U.S. Food and Drug Administration (FDA) Approved FYB201/Cimerli (ranibizumab-eqrn), the First and Only Biosimilar Interchangeable with Lucentis". Munich, Amsterdam & Zug. 2022-08-03
NLC Ventures Netherlands B.V.. (8/2/22). "Press Release: Haermonics Series A Funding Offers Pure™ Promise for Future Heart Surgery Patients". Eindhoven. 2022-08-02
MDxHealth S.A.. (8/2/22). "Press Release: MDxHealth Acquires Oncotype DX GPS Prostate Cancer Business from Exact Sciences and Reports Preliminary Half Year 2022 Results". Irvine, CA & Herstal. 2022-08-02
S-Biomedic N.V.. (8/2/22). "Press Release: S-Biomedic Welcomes Pascal Yvon to Lead Its B2B Commercial Activities". Beerse. 2022-08-02
Core Biogenesis S.A.S.. (7/28/22). "Press Release: Core Biogenesis Raises $10.5M to Accelerate Plant-Based Bioproduction". Strasbourg. 2022-07-28
Pleco Therapeutics B.V.. (7/26/22). "Press Release: Pleco Therapeutics Announces Expansion with the Incorporation of a U.S. Subsidiary and the Appointment of Michael Stalhamer as President". Nijmegen & New Jersey. 2022-07-26
NewAmsterdam Pharma Holding B.V.. (7/25/22). "Press Release: NewAmsterdam Pharma Holding B.V. and Frazier Lifesciences Acquisition Corporation Announce Merger Agreement to Create Publicly Listed Company Focused on Oral Therapies for Cardiometabolic Disea 2022-07-25
Forbion Capital Partners. (7/20/22). "Press Release: Forbion Appoints Dr. Peter Høngaard Andersen as Operating Partner and Dr. Matt Cooper as Venture Partner". Naarden. 2022-07-20
Forty51 Ventures. (7/18/22). "Press Release: Forty51 Ventures Announces the First Close of Fund I and its First Investment". Luxembourg & Basel. 2022-07-18
SHS Gesellschaft für Beteiligungsmanagement mbH. (7/18/22). "Press Release: More than 220 Million Euros for Growth and Succession Investments in European Healthcare Companies". 2022-07-18
Agomab Therapeutics N.V.. (7/13/22). "Press Release: Agomab Raises Additional $40.5 Million Through Series B Extension Bringing Total Amount to $114 Million". Ghent. 2022-07-13
Adrenomed AG. (7/12/22). "Press Release: Adrenomed Appoints David Germonpré as Chief Financial Officer". Zurich. 2022-07-12
Gilde Healthcare Partners. (7/12/22). "Press Release: Gilde Healthcare Bolsters Its Private Equity Team in Frankfurt Office". Utrecht & Frankfurt a. M.. 2022-07-12
Solvias AG. (7/12/22). "Press Release: Solvias Acquires Cergentis to Bolster Biologics and Cell & Gene Therapy Capabilities". 2022-07-12
BioInvent International AB. (7/12/22). "Press Release: BioInvent Has Successfully Carried Out a Directed Share Issue of approximately SEK 300 Million (approximately USD 28.3 Million) [ Not for US, AU, et al. ]". Lund. 2022-07-12
Phytolon Ltd.. (7/7/22). "Press Release: Biotech Food Colorant Startup Phytolon Closes $14.5 Million Series A Funding Round, Led by DSM Venturing". Yokneam Illit. 2022-07-07
Andera Partners. (7/7/22). "Press Release: Andera Partners Strengthens Its Life Sciences Team with a New Partner". 2022-07-07
ECBF Management GmbH. (7/7/22). "Press Release: ECBF Expands Its Industrial Biotech Portfolio to Offer Naturally Produced Vitamins". Luxembourg. 2022-07-07
CureVac N.V.. (7/5/22). "Press Release: CureVac Files Patent Infringement Lawsuit in Germany against BioNTech". Tübingen & Boston, MA. 2022-07-05
NewAmsterdam Pharma B.V.. (6/28/22). "Press Release: NewAmsterdam Pharma and the Menarini Group Sign Licensing Deal to Commercialize Obicetrapib in Europe". Naarden, Miami, FL & Florence. 2022-06-28
Verve Capital Partners AG (Verve Ventures). (6/24/22). "Press Release: Verve Ventures Launches Investment Fund to Support Portfolio Companies". 2022-06-24
Biotalys N.V.. (6/21/22). "Press Release: Biotalys and Novozymes Enter into Partnership to Expand Opportunities for Evoca". Ghent & Copenhagen. 2022-06-21
Ascenion GmbH. (6/21/22). "Press Release: Carma Fund I Completes First Closing of EUR 47 Million to Accelerate the Transfer of Life-Science Research into Practice". Munich & Frankfurt a. M.. 2022-06-21
Knauer Wissenschaftliche Geräte GmbH. (6/21/22). "Press Release: Knauer Wissenschaftliche Geräte Is Partnering with ModuVision". 2022-06-21
Galapagos N.V.. (6/21/22). "Press Release: Galapagos to Acquire CellPoint and AboundBio to Accelerate Access to Next-generation Cell Therapies". Mechelen, Leiden & Pittsburgh, PA. 2022-06-21
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18  next pagenext page


Picture [iito] No Tracking 650x100px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture EBD Group Whitepaper State of Innovation in Europe 650x300px

» top